A new approach to cancer vaccination yields more powerful T cells

MIT engineers developed a new way to amplify the T cell response to mRNA vaccines, using an mRNA adjuvant. This approach could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

Raccontata danews.mit.edu